CD8A and plasma cell myeloma: The tumor-priming CD8+ NKT-like cells (TPNC) exhibited potent cytotoxicity against myeloma cell lines and patient-derived RRMM samples, robust secretion of IFN-γ and TNF-α, and efficient immune synapse formation with polarized granule release.